The results revealed that overexpression of SETMAR in vitro effectively enhanced the expression of differentiation markers in thyroid cancer cells (Figure 3A; Figure S2A, Supporting Information), leading to inhibition of thyroid cancer proliferation (Figure 3C) and increased radioactive iodine uptake (Figure 3E). Here, SETMAR is linked to thyroid gland carcinoma.